BC Extra | Jun 23, 2017
Clinical News

Paper describes Affiris' PCSK9 vaccine's efficacy

In a paper published in the European Heart Journal , researchers at Affiris AG (Vienna, Austria) showed a vaccine against PCSK9 reduced cholesterol levels and atherosclerosis in mice. The vaccine, AT04A , consisted of a peptide mimic...
BC Extra | Jun 24, 2016
Financial News

Affiris raises EUR 10M

Affiris AG (Vienna, Austria) said it raised EUR 10 million ($11.3 million) from FCPB Affi GmbH and existing investors Santo Holding GmbH and MIG Funds. Affiris expects Phase I data in 1Q17 for AT04A and...
Items per page:
1 - 2 of 2